Background: Metabolic origins of mannose in glycoproteins have not been studied. Results: Glucose is the major source of N-glycan mannose, but exogenous mannose provides up to 50%. Man salvaged from glycoprotein turnover, glycogen, and gluconeogenesis is insignificant. Conclusion: Exogenous mannose is incorporated into N-glycans much more efficiently than that derived from glucose. Significance: This study provides quantitation of metabolic origins of Man in N-glycans.
Both glucose and mannose can contribute mannose to N-glycan synthesis through a common precursor, Man-6-P, 2 which is converted to Man-1-P via phosphomannomutase (PMM2) and on to GDP-mannose. For over 35 years, biosynthetic stud-ies of glycoproteins have relied on the labeling specificity of [2-3 H] mannose. Intracellular conversion to [2] [3] H]Man-6-P then leads to two mutually exclusive fates: 1) glycan synthesis or 2) MPImediated catabolism to Fru-6-P with release of 3 HOH (1). Up to 98% of the label from [2-3 H]mannose entering cells is catabolized (see Scheme 1) . When radiolabeled [ 3 H]glucose and [ 14 C]mannose are provided at physiological concentrations of 5 mM and 50 M, respectively, 80 -98% of mannose in N-glycans appears to be derived from glucose. A major factor determining the fate of [2-3 H]mannose is the PMM2:MPI ratio because both compete for Man-6-P. Reducing MPI activity either by RNAi knockdown (1) or by genetic mutation (1) increases the proportion of [2-3 H] mannose in N-glycans because [2-3 H]Man-6-P catabolism is reduced.
Other studies in cells (2) , mice (3) , and humans (4, 5) all show that surprisingly small increases in exogenous mannose dramatically improve deficient glycosylation (2) (3) (4) (5) . Patients carrying hypomorphic, life-threatening mutations in MPI suffer from coagulopathy, protein-losing enteropathy, hypoglycemia, and liver dysfunction, but most of these abnormalities reverse when patients are given ϳ0.6 g of mannose/kg/day as dietary supplements, raising their plasma mannose concentration by 3-4-fold (4) . Mannose also reverses insufficient glycosylation in patient-derived cells (2) . Mannose rescues embryonic lethality of mice carrying mutations in Pmm2 that die by mid-gestation, but when dams are given 0.9% mannose in their drinking water, pups are born and thrive (3) . However, patients with PMM2 mutations do not seem to respond to mannose therapy (6, 7) . These observations prompted us to quantitatively assess the contributions of mannose to mannose (Man M ) and glucose to mannose (Man G ) in glycosylation as well as their catabolic fate. In this study, we describe and apply new methods to metabolically label cells with stable isotopes (8) and determine the relative and quantitative contributions of mannose (Man M ) to N-glycans. We found that the contribution of exogenous mannose was previously underestimated. We also combined stable monosaccharide isotope labeling with deuterium oxide (D 2 O) and found that other potential sources of mannose including mannose salvaged from degraded glycoproteins (Man S ), glycogen (Man GL ), and gluconeogenesis do not make significant contributes to N-glycosylation. Cell Lines-Normal fibroblasts were obtained from American Type Culture Collection and Coriell Cell Repositories. All the cell lines were grown in DMEM with 1 g/liter of glucose containing 2 mM glutamine, 10% fetal bovine serum (FBS), and penicillin-streptomycin. DMEM and FBS were obtained from Mediatech and Thermo Scientific HyClone, respectively. Dialyzed FBS was obtained from Invitrogen. Glutamine and antibiotics were purchased from Omega Scientific Inc.
EXPERIMENTAL PROCEDURES
Reagents-N,O-bis[Trimethylsilyl]tri-fluoroacetamide was purchased from Thermo Scientific. All other reagents and enzymes were purchased from Sigma-Aldrich.
General Procedure for Stable Isotope Labeling and Sample Preparation-Cells were grown in a 60-mm dish to 75% confluency and labeled in DMEM glucose-free medium reconstituted with stable isotopes of glucose and mannose (5 mM and 50 M, respectively) plus 10% dialyzed FBS for 24 h unless otherwise noted.
For glycan analysis, cells were washed with PBS and extracted with chloroform methanol (2:1), deionized water, and chloroform-methanol-water (10:10:3) (9). The cell pellet was dried and resuspended in PBS, 1% SDS, and N-glycans were released by N-glycosidase F digestion. Purified glycans were hydrolyzed by 2 M trifluoroacetic acid at 100°C and dried.
For glycogen analysis, cells were extracted with 85% EtOH, and the resulting pellets were dissolved in 0.1 M NaOH, 0.1% sodium lauryl sulfate and digested with amyloglucosidase (10) Hydrolysates from N-glycan and digests from glycogen were derivatized as described in (11) , dried, resuspended in chloroform, and analyzed by GC-MS.
For metabolite analysis from glycolysis, an aliquot of 50 l of medium was extracted with 250 l of 50% methanol and 150 l of chloroform. The aqueous layer was separated and dried. The resulting solid was derivatized with 50 l of ethoxylamine hydrochloride in pyridine (20 mg/ml) at 80°C for 20 min followed by the addition of 50 l of N-tert-butyl-dimethylsilyl-Nmethyl-trifluoroacetamide and heated at 80°C for another 1 h. Derivatized samples were centrifuged, and supernatant was directly injected for GC/MS analysis (12) .
Gas Chromatography/Mass Spectrometry-Sugar analysis was done using a 15 m ϫ 0.25 mm ϫ 0.25-m SHRXI-5ms column (Shimadzu, Kyoto, Japan) on a QP2010 Plus gas chromatograph mass spectrometer (GC-MS) (Shimadzu, Kyoto, Japan) with m/z range 140 -500 and ϳ1.5-kV detector sensitivity. GC-MS ion fragment intensities were obtained using GC/MS Solution version 2.50 SU3 from Shimadzu Corp. For each fragment, the intensities were corrected for the natural abundance of each element using matrix-based probabilistic methods as described (13) (14) (15) . The 13 C/( 12 C ϩ 13 C) or 2 H/( 1 H ϩ 2 H) ratios were used to calculate isotopic labeling proportion. (Fig. 1 ). For each experiment, cells labeled without stable isotopes were included to calculate a background value to subtract from samples with stable isotopes. Error bars show the range between fragments to calculate the abundance of each sugar.
Total N-Glycan and Glycogen-The amount of mannose derived from N-glycans was analyzed by GC-MS and calculated as mannosyl units/mg of protein based on the mannose standard curve. Glucose derived from glycogen was also analyzed by GC-MS and calculated as the difference from untreated samples. A glucose standard curve was used to calculate glycogen, and its total amount was expressed as glycosyl unit per mg protein (16) . gives a molecular mass of 314, which is an isotopomer without stable isotope and defined as m0. If mannose is originated from glucose, two additional mass units will be observed (m2) because glucose contains two 13 C at C-1 and 2. The percentage of contribution from glucose was calculated as m2/(m0 ϩ m2). In a similar manner, the percentage of contribution from mannose was calculated as m1/(m0 ϩ m1). Natural abundance heavy isotope was corrected using matrix based probabilistic methods. SCHEME. 1 Mannose and glucose metabolic pathway. Sugar Phosphate Analysis-Contribution from Man and Glc to sugar phosphates (Man-6-P, Glc-6-P, and Fru-6-P) were assessed as follows. Wild type MEFs grown in 15-cm dishes were labeled with 5 mM [UL-13 C]Glc and 50 M Man or 5 mM Glc and 50 or 500 M [UL-13 C]Man for 6 h. Cells were harvested, extracted twice with 0.1 M AcOH with sonication, and centrifuged for 5 min at 15,000 ϫ g. The supernatants were combined, filtered through a membrane filter (0.22 m), and lyophilized. The resulting solid was derivatized with 50 l of hydroxylamine hydrochloride in pyridine (20 mg/ml) at 80°C for 20 min followed by the addition of 50 l of N,O-bis [trimethylsilyl]trifluoroacetamide and heated at 80°C for another 1 h. Derivatized samples were centrifuged, and the supernatant was directly injected for GC/MS analysis. First, we assigned characteristic MS fragments for sugar phosphate derivatives after phosphorylation of [1,2-13 C], [UL-13 C]Man; [1,2-13 C], [UL-13 C]Glc; and [UL-13 C]Fru by hexokinase and compared their fragment masses with standards for Man-6-P/Glc-6-P/Fru-6-P. Fragmentation series of m/z 459 and m/z 471 were used to identify which labeled species were precursors of Fru-6-P and Man6-P/Glc6-P, respectively. The contribution of [UL-13 C]Man/ Glc to Man-6-P and Glc-6-P was calculated with the m475/(m471 ϩ m475) ratio. The contribution of [UL-13 C]Man/Glc to Fru-6-P was calculated with the m462/(m459 ϩ m462) ratio (see Fig. 6B ).
The Metabolic Origins of Mannose in Glycoproteins
Other Sources of Man in N-Glycans-To assess whether either glycogen or degradation of N-glycans serves as a source of Man, cells were first labeled with [1,2-13 C]Glc/[ 12 C]Man or [1,2-13 C]Man/[ 12 C]Glc for 48 -72 h to enrich labeled glycogen or Man in N-glycans, respectively. Subsequently, cells were washed with medium without stable isotopes and chased in D 2 O/DMEM medium for 12-24 h in the presence or absence of [ 12 C]Glc/[ 12 C]Man. For the analysis, the same mass fragments were used to calculate the origin of glycogen as [1,2-13 C-2D]Glc or degradation of N-glycans as [1,2-13 C-2D]Man with average of m245/(m242 ϩ m245) and m317/(m314 ϩ m317).
PMM2 and MPI Enzyme Assays-A standard coupled assay to estimate MPI and PMM2 activities was previously described (1) .
Rate of Sugar Uptake from the Medium-Rates of sugar uptake were calculated based on the remaining amount of each sugar in the culture medium at time 0 -24 h. Cells were grown in 5 mM glucose and 50 M mannose, and an aliquot of 50 l of medium was extracted with 250 l of 50% methanol and 150 l of chloroform. The aqueous layer was separated and dried. The resulting solid was derivatized in the same manner as that described under "Sugar Phosphate Analysis" (17) . For quantitation of glucose and mannose, the total ion count peak area of the respective Z-and E-forms of the sugars, or specific mass ions, was used for calculation based on standard curves.
RESULTS
Choice of Mannose and Glucose Isotopes-Exogenous mannose and glucose can both contribute to mannose in N-glycans, as shown in Scheme 1. We supplied cells with mannose and glucose containing stable isotopes ( 2 H or 13 C) at different posi-tions in the sugar backbone. Monosaccharides incorporated into cellular N-glycans were released by N-glycosidase F digestion and hydrolyzed. The released monosaccharides were converted to aldonitrile acetate derivatives for analysis by GC-MS. Mannose and glucose were baseline-separable by GC ( Fig. 2A) , and each produced similar mass fragments. By varying the locations of the heavy isotope on each precursor sugar ( Fig. 2B) , we could distinguish their origin in N-glycans as being from Glc or Man. (Fig. 2C) (11) . We tested combinations of [1, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] 
]glucose, which showed a 26% reduction in incorporation into N-glycans, presumably due to the presence of two bulky deuterium labels at the 6-position, which reduced either the rate of glucose transport or the subsequent metabolism (data not shown). We chose [1,2-13 C]glucose and [4-13 C]mannose for further studies because they gave the clearest signals using the mass isotopomer patterns of m/z 314 and m/z 242 aldonitrilesugar fragments (ϩ2 or ϩ1 mass unit labeling, respectively). Exchanging the location of the labels between the two precursors had no effect on their relative proportions in N-glycans. Samples containing as little as 5% incorporated heavy isotope gave reliable values above natural abundance background for each isotope after 2 h of labeling (Fig. 3A) . Fibroblasts were routinely labeled for 16 -24 h without deleterious effects to the cells. Chasing heavy isotope-labeled cells with unlabeled medium showed that N-glycan mannose (content ϭ 24 nmol/mg of protein) has a t1 ⁄2 of 24 h (Fig. 3B) .
Fate and Distribution of Mannose-Under physiological concentrations (5 mM glucose, 50 M mannose), several studies have shown that only a small amount of exogenous [2-3 H]mannose is incorporated into glycans (ϳ2%), whereas most is released as 3 HOH (98%) (1). Using stable isotopes and unlabeled sugars, we found that fibroblasts take up exogenous mannose at a rate of 9.4 -22 nmol/mg/h protein and glucose at 1500 -2200 nmol/mg/h protein (Table 1) . Among five different cell lines tested, glucose and mannose contribution to N-glycans ranged from 0.1-0.4 and 0.1-0.2 nmol/mg/h, respectively, showing that, relative to their uptake rates, mannose is incorporated into N-glycans (1-2%) much more efficiently than glucose (0.01-0.03%). Under these labeling conditions, conversion of [4-13 C]mannose to other monosaccharides found in N-glycans or to glycogen is undetectable (Table 1) . To assess the contribution of mannose (to glucose) in glycogen and glycolysis, control fibroblasts were labeled with either 5 mM [1,2-13 C]Glc/50 M Man (shown as 13 C-Glc) or 5 mM Glc/1 mM [1,2-13 C]Man (shown as 13 C-Man) for 24 h, respectively. Under the first condition, 13 C-Man is undetectable in glycogen or in glycolytic products. At a 20-fold higher concentration, mannose is clearly metabolized identically to glucose because it shows a similar distribution in glycogen and in pyruvate, lactate, and alanine in the medium (Fig. 4, A and B) . MARCH 7, 2014 • VOLUME 289 • NUMBER 10 contribute to galactose and N-acetylglucosamine in N-glycans. It is undetectable at 50 M; however, at 1 mM, 30% of galactose and 50% of N-acetylglucosamine were derived from Man (Fig.  4, D and E) . Mannose presumably competes for glucose transport at 1 mM because it reduces the uptake of 2-deoxy-[2-3 H]glucose by 40% (data not shown).
The Metabolic Origins of Mannose in Glycoproteins
Mannose and Glucose Take "Metabolic Detours" within the Cell-Scores of previous studies using [2-3 H]mannose indicated two mutually exclusive fates: conversion to Fru-6-P (and loss of 3 HOH) and catabolism via glycolysis or, alternatively, conversion to [2-3 H]Man-1-P and incorporation into glycans. Stable isotope labeling suggests that the route is more complex. The MPI epimerase reaction requires loss of a hydrogen atom at C-2 of the substrate followed by its replacement with a hydrogen atom from water, or deuterium in the presence of D 2 O. To test the assumption that conversion to Fru-6-P is irreversible, we labeled fibroblast cells with [1,2-13 C]mannose in the presence of D 2 O. Unexpectedly, this introduced deuterium was incorporated into about one-third of the mannose-derived molecules found in N-glycans (Fig. 5B ). This shows that a substantial amount of [1,2-13 C]Man-6-P is not directly incorporated into the glycosylation pathway, but is first converted to [1, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]Fru-6-P and then reconverted to [1, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C-2-D]Man-6-P (Man F ) before incorporation into N-glycans. (Fig. 5A ). This reaction is totally dependent on MPI because the deuteriumlabeled product (Man F ) is not produced in Mpi-null mouse embryonic fibroblasts (Fig. 5C ). This suggests that previous determinations of the proportion of [2-3 H]mannose incorporated into glycans are probably substantially underestimated because loss of 3 HOH from Man-6-P was assumed to indicate irreversible commitment to further catabolism.
To test whether similar metabolic detours occur in the utilization of glucose, we incubated cells with [1, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]glucose in the presence of D 2 O. We first confirmed that all glucose incorporated into glycans as mannose (Man G ) trafficked through an MPI-dependent pathway as [1,2-13 C-2-D]Man-6-P (Scheme 2), as evidenced by the extra mass labeling of mannose in glycans (data not shown). Next, we assayed incorporation into glycogen. Although glucose is primarily used as an energy source, a substantial amount is incorporated into glycogen (content ϭ 404 Ϯ 37 nmol/mg of protein) through a pathway that requires intermediates Glc-6-P, Glc-1-P, and UDP-Glc (Scheme 1). Labeling cells with [1, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]glucose in the presence of D 2 O showed that 80% of glucose incorporated into glycogen is first converted into [1,2-13 C]Fru-6-P via phosphoglucose isomerase (Glc-6-P 7 Fru-6-P) and then back to [1, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C-2-D]Glc-6-P prior to incorporation into glycogen (data not shown). Together these results suggest that Fru-6-P may serve as a checkpoint for exogenous mannose directed toward glycosylation and glucose directed toward glycogen because this intermediate is not on the "direct" biosynthetic pathway for either product.
Multiple Metabolic Pools of Fru-6-P-To investigate the hypothesis of Fru-6-P as metabolic checkpoint for glycosyla- tion, cells were labeled with either [UL-13 C]glucose or [UL-13 C]mannose for 6 h, harvested, extracted, and dried. Dried samples were derivatized as oxime-TMS and subjected to GC-MS analysis. Man-6-P, Glc-6-P, and Fru-6-P are well separated on GC as their corresponding derivatives (Fig. 6A) . The origin of sugar phosphate was determined by characteristic fragments of m/z 459 (for Fru-6-P) or m/z 471 (for Man-6-P/ Glc-6-P) and their enrichment from [UL-13 C]sugar (ϩ3 or ϩ4 mass unit labeling, respectively) ( Fig. 6B ). As expected, contribution from glucose and mannose to Man-6-P (Man G -6-P, Man M -6-P) was proportional to Man G and Man M found in N-glycans (Fig. 7) . However, 13 C-mannose was not detected in Fru-6-P, although the D 2 O experiment showed that a substantial amount of Man-6-P is converted to Fru-6-P prior to N-glycosylation (Fig. 5B) . Increasing the concentration of mannose to 500 M still did not show detectable contribution to the total cellular Fru-6-P pool (Fig. 7) . We conclude that the Fru-6-P derived from exogenous mannose does not equilibrate with the total cellular pool of Fru-6-P, which is overwhelmingly derived from glucose.
Other Sources of Mannose for N-Glycans-Previous studies suggest that glycogen can serve as a reserve source of mannose for glycosylation (18, 19) . To test this concept, we preincubated control fibroblasts with [1, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]glucose for 2 days to label Ͼ80% of glycogen. These cells were then incubated for 24 h in D 2 O and various concentrations of unlabeled glucose. Mannose derived directly from [1, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]glucose (Man G ) in N-glycans will increase by ϩ2 mass units, but mannose in glycans derived from glycogen (Man GL ) during the D 2 O chase will have an additional mass unit (deuterium) at the C-2 position because all of it must transit through Fru-6-P via MPI (Scheme 2). However, no detectable (Ͻ5%) glycogen-derived label (Man GL ) was seen under standard culture conditions (5 mM glucose) or when glucose was reduced to either 1.0 mM or 0.5 mM (Fig. 8A ). Under these conditions of limiting glucose, all cellular glycogen was depleted during the 24-h D 2 O chase. As endoplasmic reticulum stress is known to increase Man-6-P from glycogen, we tested an endoplasmic reticulum stress inducer, DTT; however, it did not increase incorporation of glycogen-derived mannose into N-glycans (Fig. 8A) . Cells cultured in the complete absence of glucose and mannose for 12 h had very little metabolic activity, and only under these severe conditions, a small amount of glycogen-derived mannose was seen in N-glycans (Fig. 8A) . These results make it unlikely that glycogen routinely provides mannose for glycan synthesis, even when glucose is limiting. Similar experiments using two different hepatoma cell lines, HepG2 and Hep3B, led to similar conclusions (data not shown). We also considered the possibility that gluconeogenesis provides mannose for N-glycans, but found no evidence that any label (Ͻ5%) was derived from either labeled pyruvate or labeled glycerol under our standard labeling conditions (Fig. 8B) . Increasing the concentration of labeled pyruvate or glycerol to 2 mM and extending labeling time to 48 h also did not show any contribution of gluconeogenesis-derived mannose to N-glycans either (data not shown).
Reutilization of Salvaged Mannose-Previous studies showed that mannose released from N-glycan processing is rapidly transported from the endoplasmic reticulum/Golgi back into the medium (9, 20) . However, the fate of mannose derived from glycoprotein degradation is unknown. To address this question, we labeled fibroblasts for 72 h with 0.5 mM [1,2-13 C]mannose to replace ϳ60% of the mannose in glycoproteins with Man M . Following a brief washout in unlabeled medium, cells were incubated for 12 h in D 2 O with 12 C-monosaccharides. This is sufficient time to turnover ϳ25% of cellular N-glycans (Fig. 3) . Based on the results presented above, reincorporation of mannose into newly synthesized glycoproteins would require Man-6-P, and ϳ50% of those molecules would be converted to Fru-6-P and acquire an additional deuterium at C-2. Analysis of N-glycans showed that no salvaged mannose (Man S ) with deuterium was found (Ͻ5%) under physiological condition (5 mM glucose, 50 M mannose). In the complete absence of glucose and mannose during the incubation with D 2 O, we did detect a small contribution of mannose from salvaged N-glycans (Man S ). However, under normal conditions, we conclude that the mannose salvaged from N-glycans (Man S ) does not make a significant contribution to newly synthesized N-glycans (Fig. 8C) .
Direct Mannose Contribution in Various Cell Lines-Cancer cell lines are known to possess extremely active sugar metabolism. To evaluate whether they have a unique mannose flux, a wide variety of tumor cell lines were labeled with [4-13 C]mannose and [1, [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]glucose to determine the contribution from each monosaccharide (Fig. 9A ). Mannose contribution varied from ϳ10% to ϳ45% at 50 M mannose and reached up to 75% at 200 M mannose. Direct mannose contribution generally correlates with the PMM2:MPI ratio, i.e. more mannose is delivered to glycosylation when the ratio is high (Fig. 9B ). However, some exceptions suggest that other factors, such as a putative mannose-preferential transporter, may also influence the contribution of Man M .
DISCUSSION
Small amounts of dietary mannose rescue glycosylation-deficient cells (2), mice (3), and humans (4, 5), suggesting its efficient use for glycosylation. Radiolabel tracer studies using [2-3 H]mannose indicate that the great majority (98%) is catabolized and only a small portion appears in N-glycans. The low glycan labeling efficiency seems at odds with the remarkable physiological benefits. Which perspective is accurate? [2-3 H]Mannose labeling has shortcomings because it does not indicate: 1) the quantity of mannose incorporated; 2) the relative contributions of glucose and mannose to Man-6-P; or 3) the fate of exogenous mannose.
To address these issues, we developed stable isotope-labeled methods using glucose and mannose at physiological concentrations, 5 mM and 50 M, respectively. We detected the origin of mannose of N-glycans based on mass fragment analysis using GC-MS. This efficient, nontoxic, and inexpensive method provides both the actual and the relative amounts derived from each monosaccharide.
We showed that the amount of mannose directly incorporated into N-glycans is ϳ50% greater than previously estimated.
Although conversion of [2-3 H]Man-6-P to Fru-6-P through a cis-enediol intermediate indeed releases 3 HOH from 3 H at C-2 in the medium, the reverse reaction regenerates Man-6-P, or 2-(D)-Man-6-P if the reaction is performed in D 2 O.
Stable isotopes also allowed us to determine unambiguously whether mannose in N-glycans is derived from other sources. We found no evidence that gluconeogenic precursors (pyruvate or glycerol) contribute to N-glycan mannose under physiological conditions. Previous studies suggested that endoplasmic reticulum stress (21) or reduced exogenous glucose (22) could recruit glycogen for glycosylation, but we could not find any evidence for this. The one exception was when cells were completely deprived of all exogenous glucose and mannose for 12 h. We also showed that mannose salvaged from N-glycan degradation did not make a significant contribution to mannose in N-glycans under normal conditions. Stable isotopes can be used to track mannose under nonphysiological conditions as well. Increasing mannose concentration to 1 mM shows that it is metabolized identically to glucose, with similar contributions to glycogen, and to pyruvate, lactate, and alanine in the medium. In the complete absence of glucose, mannose salvaged from N-glycans or glycogen-derived glucose shows small contributions to N-glycans.
The direct contribution of mannose to N-glycans varies among different cell lines. The ratio of PMM2:MPI activities is an important determining factor; however, other undefined factors may also be important because some cell lines show large increases in direct mannose incorporation into glycans when exogenous mannose is increased ( Fig. 9A, C2C12 , U87, Hep3B), whereas others (293T, CaCo2) show only modest increases. Other factors such as levels and activities of the GDP-Man-pyrophosphorylase, dolichol-phosphate-mannose (Dol-P-Man) synthase, and mannosyltransferases are also known contributors, but their roles need to be re defined in light of the new approach and direct mannose metabolism.
A much higher proportion of transported mannose is used for N-glycosylation (ϳ1.8%) when compared with glucose (0.026%), and a lingering question is how a 100-fold lower concentration of exogenous mannose versus glucose can contribute nearly 50% of the mannose to N-glycans. One explanation is that mannose employs a high affinity mannose-preferential or -specific hexose transporter that directs it to glycosylation. Studies using [2-3 H]Man labeling suggested the existence of such a GLUT-like mannose transporter (23), but no specific transporter was identified. A kidney-localized sodium-glucose linked transporter (SGLT)-type mannose-specific transporter was described (24) that may reabsorb mannose. nose use in glycosylation might simply result from ␣and ␤-Man-6-P and the anomeric preferences of MPI and PMM2.
In summary, the significant findings of this study employing stable isotopes combined with D 2 O were: 1) the direct contribution of mannose to glycoprotein synthesis has been underestimated by at least 1.5-fold; 2) metabolic origin of mannose into N-glycosylation and fate of mannose is unambiguously identified; and 3) PMM2:MPI ratio plays a dominant, but not exclusive role in determining the contribution of mannose to N-glycans.
